PharmaEssentia

PharmaEssentia FCF Yield

Free Cash Flow Yield of PharmaEssentia (6446.TW) as of Nov 19, 2026.

FCF Yield

-

Last updated:

Free Cash Flow Yield of PharmaEssentia is 2026 - . Free Cash Flow Yield of PharmaEssentia was 2025 - . It decreases by % lower compared to the previous year.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

PharmaEssentia Stock analysis

What does PharmaEssentia do? PharmaEssentia Corp develops and sells drugs for hematology, infectious diseases, dermatology, and neurology. Its products include KX01, P1101, Polycythemia Vera (PV), PEG-GCSF, and PEG-EPO, targeting conditions like MPN, hepatitis C, psoriasis, and multiple sclerosis. The company sells these drugs domestically in Taipei and internationally to overseas markets. The firm generates revenue through the sale of its pharmaceutical products to healthcare providers and distributors. Its research and development focus on new drugs for specific medical conditions, with products distributed across multiple therapeutic areas. PharmaEssentia Corp's market segments include hematology, infectious disease, dermatology, and neurology, serving both local and global healthcare systems. PharmaEssentia Corp's business model centers on developing and commercializing prescription drugs for specialized medical treatments. The company's product portfolio targets high-demand therapeutic areas, with sales driven by both domestic and international distribution channels. Its revenue streams are derived from the ongoing sale of established products and the pipeline of new drug developments. PharmaEssentia is one of the most popular companies on Eulerpool.

Frequently Asked Questions about PharmaEssentia stock

On Eulerpool you can find the complete historical development of Free Cash Flow Yield PharmaEssentia since 2006 – with annual values, charts, and detailed analysis.

FCF Yield measures the free cash flow per share relative to the stock price. It indicates how much cash a company generates for each dollar invested.

To evaluate Free Cash Flow Yield's, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Free Cash Flow Yield.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Free Cash Flow Yield's PharmaEssentia with sector peers and the industry average to assess whether it is attractive.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Valuation — PharmaEssentia

All Key Metrics — PharmaEssentia